Defining the Role of Pharmacists in Polycythemia VeraVideo Categories: Pharmacy
Supported through funding from Incyte
November 19, 2014
Costs of Treatment in Polycythemia Vera
Ken Schaecher, MD, presents his own personal opinion on the challenges of concerns related to costs of treatment by oncologists and why they should not ignore them. Supported through funding from Incyte
July 25, 2018
The Best Molecular Biomarkers Available for Informing Immunotherapy of Cancer
Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.